Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
van de Wal RM, van der Harst P, Gerritsen WB, van der Horst F, Plokker TH, Gansevoort RT, van Gilst WH, Voors AA. van de Wal RM, et al. Among authors: gansevoort rt. J Renin Angiotensin Aldosterone Syst. 2007 Dec;8(4):177-80. doi: 10.3317/jraas.2007.029. J Renin Angiotensin Aldosterone Syst. 2007. PMID: 18205096 Free article. Clinical Trial.
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Atthobari J, Brantsma AH, Gansevoort RT, Visser ST, Asselbergs FW, van Gilst WH, de Jong PE, de Jong-van den Berg LT; PREVEND study group. Atthobari J, et al. Among authors: gansevoort rt. Nephrol Dial Transplant. 2006 Nov;21(11):3106-14. doi: 10.1093/ndt/gfl244. Epub 2006 May 23. Nephrol Dial Transplant. 2006. PMID: 16720593 Clinical Trial.
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ; PREVEND IT Study Group. Atthobari J, et al. Among authors: gansevoort rt. Clin Ther. 2006 Mar;28(3):432-44. doi: 10.1016/j.clinthera.2006.03.012. Clin Ther. 2006. PMID: 16750458
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
Brouwers FP, Asselbergs FW, Hillege HL, de Boer RA, Gansevoort RT, van Veldhuisen DJ, van Gilst WH. Brouwers FP, et al. Among authors: gansevoort rt. Am Heart J. 2011 Jun;161(6):1171-8. doi: 10.1016/j.ahj.2011.03.028. Epub 2011 May 11. Am Heart J. 2011. PMID: 21641365 Free article. Clinical Trial.
The fibrosis marker galectin-3 and outcome in the general population.
de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P. de Boer RA, et al. Among authors: gansevoort rt. J Intern Med. 2012 Jul;272(1):55-64. doi: 10.1111/j.1365-2796.2011.02476.x. Epub 2011 Nov 18. J Intern Med. 2012. PMID: 22026577 Free article.
Plasma renin and outcome in the community: data from PREVEND.
de Boer RA, Schroten NF, Bakker SJ, Mahmud H, Szymanski MK, van der Harst P, Gansevoort RT, van Veldhuisen DJ, van Gilst WH, Hillege HL. de Boer RA, et al. Among authors: gansevoort rt. Eur Heart J. 2012 Sep;33(18):2351-9. doi: 10.1093/eurheartj/ehs198. Epub 2012 Jul 17. Eur Heart J. 2012. PMID: 22807466
725 results